FDA OKs First Drug (Kanuma) for Rare Enzyme DiseaseFDA OKs First Drug (Kanuma) for Rare Enzyme Disease

Produced with the help of genetically engineered chickens, the drug treats adults and children with lysosomal acid lipase deficiency, a potentially life-threatening genetic disorder. FDA Approvals
Source: Medscape Pulmonary Medicine Headlines - Category: Respiratory Medicine Tags: Gastroenterology News Alert Source Type: news